TGFB1 and osteosarcoma: After the combined use of Dio3os silencing and TGF-β signaling pathway activator (TGF-β1), the results revealed that acting the TGF-β signaling pathway restored the affection of Dio3os silencing on inhibiting the metastasis, migration, and invasion of osteosarcoma in vivo and in vitro [77].